Kazia Therapeutics Expands Paxalisib Clinical Trial into HR+/HER2- Breast Cancer, Supported by Preclinical Data Showing Strong Clinical Activity and Safety in HR+ Breast Cancer
Preclinical Data Show Paxalisib Combined With Standard-of-Care Therapy Is Well Tolerated and…
September 1, 2026
Malaysia's Cybersecurity Leaders to Convene at the 34th Edition Cyber Security Summit Malaysia 2026
Summit to Bring Together More Than 150 CISOs, CIOs, Government Officials and…
September 1, 2026
OncoC4 Appoints Dr. Steve Chen, JD, PhD as General Counsel
ROCKVILLE, Md., Sept. 1, 2026 /PRNewswire/ — OncoC4, Inc., a late clinical-stage…
September 1, 2026
Medtronic reports first quarter fiscal 2027 results; delivers broad-based portfolio performance and raises fiscal 2027 guidance
Strength across the company’s largest franchises, new growth platforms, and recent portfolio…
September 1, 2026
ICAC Commissioner in Vienna to meet new UNODC Chief to foster anti-corruption strategic collaboration and unveil ICAC's AI enforcement system "Tianma" at UNODC's anti-graft conference
